Antiviral activity of CYC202 in HIV-1-infected cells (Q28292152)

1

0 references

Cynthia de La Fuente

2

0 references

Sergie Nekhai

3

0 references

Anna Barnett

4

0 references

Athos Gianella-Borradori

5

0 references

Anne Pumfery

Journal of Biological Chemistry

6

0 references

language of work or name

English

0 references

publication date

28 January 2005

0 references

published in

0 references

volume

280

0 references

page(s)

3029-42

0 references

issue

4

0 references

cites work

Multiple mutations in HIV-1 reverse transcriptase confer high-level resistance to zidovudine (AZT)

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M406435200

HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M406435200

Implications of antiretroviral resistance on viral fitness

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M406435200

Origin of human immunodeficiency virus type 1 quasispecies emerging after antiretroviral treatment interruption in patients with therapeutic failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M406435200

HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M406435200

Activation of infectious virus from latent human immunodeficiency virus infection of monocytes in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M406435200

Virus isolation from and identification of HTLV-III/LAV-producing cells in brain tissue from a patient with AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M406435200

In vivo fate of HIV-1-infected T cells: quantitative analysis of the transition to stable latency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M406435200

Dual infection of the central nervous system by AIDS viruses with distinct cellular tropisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M406435200

The restricted nature of HIV-1 tropism for cultured neural cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M406435200

Specific tropism of HIV-1 for microglial cells in primary human brain cultures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M406435200

Infection of monocyte/macrophages by human T lymphotropic virus type III.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M406435200

Efficient isolation and propagation of human immunodeficiency virus on recombinant colony-stimulating factor 1-treated monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M406435200

Replication of HIV-1 in primary monocyte cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M406435200

Mononuclear phagocytes and the human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M406435200

Cytokines alter production of HIV-1 from primary mononuclear phagocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M406435200

Proliferation-dependent replication in primary macrophages of macrophage-tropic HIV type 1 variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M406435200

HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M406435200

Quiescent T lymphocytes as an inducible virus reservoir in HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M406435200

Low levels of deoxynucleotides in peripheral blood lymphocytes: a strategy to inhibit human immunodeficiency virus type 1 replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M406435200

An inducible transcription factor activates expression of human immunodeficiency virus in T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M406435200

Tumor necrosis factor-α, interleukin 1, and phorbol myristate acetate are independent activators of NF-κB which differentially activate T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M406435200

Activation of integrated provirus requires histone acetyltransferase. p300 and P/CAF are coactivators for HIV-1 Tat

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M406435200

Identification of a cyclin subunit required for the function of Drosophila P-TEFb

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M406435200

Upregulation of cyclin T1/CDK9 complexes during T cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M406435200

Induction of TAK (cyclin T1/P-TEFb) in purified resting CD4(+) T lymphocytes by combination of cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M406435200

A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M406435200

Interaction between cyclin T1 and SCF(SKP2) targets CDK9 for ubiquitination and degradation by the proteasome

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M406435200

Loss of G(1)/S checkpoint in human immunodeficiency virus type 1-infected cells is associated with a lack of cyclin-dependent kinase inhibitor p21/Waf1

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M406435200

HIV-1 Tat-associated RNA polymerase C-terminal domain kinase, CDK2, phosphorylates CDK7 and stimulates Tat-mediated transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M406435200

HIV-1 Tat interaction with RNA polymerase II C-terminal domain (CTD) and a dynamic association with CDK2 induce CTD phosphorylation and transcription from HIV-1 promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M406435200

Cell cycle-regulated transcription by the human immunodeficiency virus type 1 Tat transactivator

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M406435200

Cdk2 knockout mice are viable

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M406435200

Cyclin E ablation in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M406435200

Cyclin-dependent kinase 2 is essential for meiosis but not for mitotic cell division in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M406435200

Enhancement of the p300 HAT activity by HIV-1 Tat on chromatin DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M406435200

Glycogen synthase kinase3 beta phosphorylates serine 33 of p53 and activates p53's transcriptional activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M406435200

Overexpression of p21(waf1) in human T-cell lymphotropic virus type 1-infected cells and its association with cyclin A/cdk2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M406435200

Inhibition of human immunodeficiency virus type 1 transcription by chemical cyclin-dependent kinase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M406435200

Selection of insulinoma cell lines with resistance to interleukin-1beta- and gamma-interferon-induced cytotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M406435200

The Tat/TAR-dependent phosphorylation of RNA polymerase II C-terminal domain stimulates cotranscriptional capping of HIV-1 mRNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M406435200

Rapid in vitro selection of human immunodeficiency virus type 1 resistant to 3'-thiacytidine inhibitors due to a mutation in the YMDD region of reverse transcriptase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M406435200

In vitro isolation and identification of human immunodeficiency virus (HIV) variants with reduced sensitivity to C-2 symmetrical inhibitors of HIV type 1 protease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M406435200

Characterization of human immunodeficiency viruses resistant to oxathiolane-cytosine nucleosides

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M406435200

Pharmacological cyclin-dependent kinase inhibitors as HIV-1 antiviral therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M406435200

The role of cyclin D2 and p21/waf1 in human T-cell leukemia virus type 1 infected cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M406435200

A novel approach to develop anti-HIV drugs: adapting non-nucleoside anticancer chemotherapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M406435200

Roscovitine, a specific inhibitor of cellular cyclin-dependent kinases, inhibits herpes simplex virus DNA synthesis in the presence of viral early proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M406435200

Pharmacological cyclin-dependent kinase inhibitors inhibit replication of wild-type and drug-resistant strains of herpes simplex virus and human immunodeficiency virus type 1 by targeting cellular, not viral, proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M406435200

The cyclin-dependent kinase inhibitor roscovitine inhibits the transactivating activity and alters the posttranslational modification of herpes simplex virus type 1 ICP0.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M406435200

cdc2 cyclin-dependent kinase binds and phosphorylates herpes simplex virus 1 U(L)42 DNA synthesis processivity factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M406435200

Effects of pharmacological cyclin-dependent kinase inhibitors on viral transcription and replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M406435200

Inhibition of cellular Cdk2 activity blocks human cytomegalovirus replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M406435200

Human cytomegalovirus (HCMV) IE1 plays role in resistance to apoptosis with etoposide in cancer cell line by Cdk2 accumulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M406435200

Inhibition of S-phase cyclin-dependent kinase activity blocks expression of Epstein-Barr virus immediate-early and early genes, preventing viral lytic replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M406435200

Roscovitine, a cyclin-dependent kinase inhibitor, prevents replication of varicella-zoster virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M406435200

Viral and cellular kinases are potential antiviral targets and have a central role in varicella zoster virus pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M406435200

Inhibition of HTLV-1 transcription by cyclin dependent kinase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M406435200

Use of a multi-virus array for the study of human viral and retroviral pathogens: gene expression studies and ChIP-chip analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M406435200

Cyclin-dependent kinases as cellular targets for antiviral drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M406435200

Different patterns of immune responses but similar control of a simian-human immunodeficiency virus 89.6P mucosal challenge by modified vaccinia virus Ankara (MVA) and DNA/MVA vaccines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M406435200

Inhibiting HIV-1 infection in human T cells by lentiviral-mediated delivery of small interfering RNA against CCR5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M406435200

Small interfering RNA-mediated gene silencing in T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M406435200

RNA interference directed against viral and cellular targets inhibits human immunodeficiency Virus Type 1 replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M406435200

Inhibition of human immunodeficiency virus type 1 replication by RNA interference directed against human transcription elongation factor P-TEFb (CDK9/CyclinT1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M406435200

Bispecific short hairpin siRNA constructs targeted to CD4, CXCR4, and CCR5 confer HIV-1 resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M406435200

Identification of cell surface targets for HIV-1 therapeutics using genetic screens

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M406435200

Control of HIV-1 replication by RNA interference

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M406435200

RNA interference against retroviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M406435200

HIV-1 Tat-mediated apoptosis in human brain microvascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M406435200

Erratum: Biochemical networking contributes more to genetic buffering in human and mouse metabolic pathways than does gene duplication

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M406435200